Table 5.

Effect of RSS on Quality-of-Life scores, body weight, and Karnofsky Performance Score in malignant brain tumor patients

	Scale	Mean ± SE		p-value
Functional scale		Before treatment	After treatment
	Physical Functioning	71.87 ± 2.62	69.39 ± 2.72	NS
	Role Functioning	67.77 ± 3.32	69.81 ± 2.84	NS
	Emotional Functioning	73.01 ± 2.01	72.51 ± 2.20	NS
	Cognitive Functioning	75.00 ± 2.39	74.84 ± 2.21	NS
	Social Functioning	72.64 ± 2.93	73.43 ± 2.84	NS
Symptoms scale	Fatigue	35.11 ± 2.44	34.59 ± 2.76	NS
	Nausea & Vomiting	8.65 ± 1.57	2.99 ± 0.97	0.001
	Pain	25.47 ± 2.49	20.60 ± 2.17	NS
	Dyspnoea	10.38 ± 2.16	8.81 ± 1.75	NS
	Insomnia	14.78 ± 2.45	16.04 ± 2.42	NS
	Appetite Loss	17.61 ± 2.69	16.98 ± 2.24	NS
	Constipation	16.35 ± 2.37	7.86 ± 1.64	0.01
	Diarrhoea	2.83 ± 1.19	1.89 ± 0.98	NS
	Financial Difficulties	38.36 ± 3.02	40.88 ± 3.14	NS
Global scale		52.75 ± 1.85	54.32 ± 2.14	NS
Body weight (n = 96)		59.37 ± 2.06	61.32 ± 1.84	0.05
Kernofsky performance score (n = 110)		72.82 ± 1.10	76.18 ± 1.42	0.01

Data presented in Mean ± SE, the difference in the mean scores were compared by using paired ‘t’ test.